Stock IINN INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Inspira Technologies Oxy B.H.N. Ltd.

Equities

IINN

IL0011715781

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
2.18 USD +3.81% Intraday chart for Inspira Technologies Oxy B.H.N. Ltd. -1.36% +105.66%
05-02 Inspira? Announces Start of Production of the Inspira? Art100 CI
04-17 Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Inspira? Announces Start of Production of the Inspira? Art100
CI
Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures
CI
Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation
MT
Inspira?? and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth Causes Bloodstream Infections
CI
Inspira? Technologies Oxy B.H.N. Ltd. Announces Program to Pioneer the Applicable Use of the INSPIRA? ART100 Device for an Artificial Womb
CI
Inspira Technologies Oxy B.H.N. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Inspira Technologies OXY B.H.N. Ltd. Announces AMAR Regulatory Submission of the INSPIRA? ART100, to Enter the Southeast Asia and South American Markets
CI
Inspira Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
CI
Inspira Technologies Oxy B.H.N. Ltd. Plans to Report the Primary Results for A Core Blood Oxygenation Technology Within Days
CI
Inspira Technologies Oxy B.H.N. Ltd. Announces Approval from the U.S. Food & Drug Administration for its INSPIRA ART100 in the First Half of 2024
CI
Inspira Technologies OXY B.H.N. Ltd. Introduces High-End Platform for Bio-Mimicking Blood parameters for Development and Testing of Core Technologies
CI
Inspira Gets US Patent Approval for Orbiting Blood Oxygenation Delivery System; Shares Rise
MT
Inspiratm Technologies OXY B.H.N. Ltd. Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
CI
Inspira? Technologies Collaborates with Shamir Medical Center
CI
Inspira? Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 Inspira? Art Devices
CI
Inspira Technologies Oxy B.H.N. Ltd. Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for A New Disposable Perfusion Market Opportunity
CI
Inspira Technologies Oxy B.H.N. Ltd. Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA? ART100 Device
CI
Inspira Technologies Shares Rise After Promising Results for Blood Sensor; Raises $3.9 Million via Offering
MT
Inspira Technologies OXY BHN Ltd. Announces 95% Accuracy Results for HYLA?? Blood Sensor, Planning FDA Submission for Clearance in 2024
CI
Inspira Collaborates with Ennocure for Development of Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IINN Stock
  4. News Inspira Technologies Oxy B.H.N. Ltd.
  5. Highlights